Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

OBJECTIVE: To investigate whether baseline CSF biomarkers are associated with hippocampal atrophy rate as a measure of disease progression in patients with Alzheimer disease (AD), patients with mild cognitive impairment (MCI), and controls, controlling for baseline neuropsychological and MRI finding...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Henneman, W J.P., Vrenken, H, Barnes, J, Sluimer, I C., Verwey, N A., Blankenstein, M A., Klein, M, Fox, N C., Scheltens, P, Barkhof, F, van der Flier, W M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Academy of Neurology 2009
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839552/
https://ncbi.nlm.nih.gov/pubmed/19770469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181b879ac
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller